Skip to main content

Psoriasis Excellence Forum

wells
Clinical Insights
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
Blauvelt
Clinical Insights
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that...
03/02/2026
The Dermatologist
Krueger
Clinical Insights
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr...
03/02/2026
The Dermatologist
Dr Blauvelt
Conference Coverage
02/22/2026
Riya Gandhi, MA
A clinical update on oral IL-23 therapy for plaque psoriasis, highlighting icotrokinra phase 3 data, superiority vs deucravacitinib, TYK2 inhibitors (zasocitinib, envudeucitinib), and patient-centered treatment strategies.
A clinical update on oral IL-23 therapy for plaque psoriasis, highlighting icotrokinra phase 3 data, superiority vs deucravacitinib, TYK2 inhibitors (zasocitinib, envudeucitinib), and patient-centered treatment strategies.
A clinical update on oral IL-23...
02/22/2026
The Dermatologist
Dr Wells
Conference Coverage
02/22/2026
Riya Gandhi, MA
A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic...
02/22/2026
The Dermatologist
Dr Weber
Conference Coverage
02/20/2026
Riya Gandhi, MA
A cardio-dermatology update on psoriasis, psoriatic arthritis, coronary computed tomography angiography, coronary artery calcium-AI imaging, and cardiovascular risk prevention in immune-mediated inflammatory disease.
A cardio-dermatology update on psoriasis, psoriatic arthritis, coronary computed tomography angiography, coronary artery calcium-AI imaging, and cardiovascular risk prevention in immune-mediated inflammatory disease.
A cardio-dermatology update on...
02/20/2026
The Dermatologist
Dr Weber
Conference Coverage
02/20/2026
Riya Gandhi, MA
A clinical update on GLP-1 receptor agonists in psoriasis and psoriatic arthritis, highlighting cardiovascular outcomes, SELECT trial data, obesity-driven inflammation, and combination therapy results.
A clinical update on GLP-1 receptor agonists in psoriasis and psoriatic arthritis, highlighting cardiovascular outcomes, SELECT trial data, obesity-driven inflammation, and combination therapy results.
A clinical update on GLP-1...
02/20/2026
The Dermatologist
Blauvelt
Videos
02/17/2026
Riya Gandhi, MA
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how...
02/17/2026
The Dermatologist
psoriasis
Quiz
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
psoriasis
Quiz
11/06/2025
Jessica Garlewicz
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best reflects a central message of World Psoriasis Day 2025 and its emphasis on comorbidities in psoriatic disease?
Which of the following best...
11/06/2025
The Dermatologist